Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
Administrative courts block preventive consumer protection

NEW ON THE MARKET
Andexanet alfa (ONDEXXYA) – antidote for rivaroxaban and apixaban

THERAPY FROM A CRITICAL VIEWPOINT
Breast cancer with postmenopausal hormone treatment
Ticagrelor or prasugrel in acute coronary syndrome?

IN BRIEF
Fremanezumab (AJOVY) in treatment-refractory migraine
Nitrosamine in all ranitidine preparations?

CURRENT ADR NETWORK REPORT
Itraconazole and hypertension  free article 

SIDE EFFECTS
Trismus with the ADHD drug methylphenidate (RITALIN, generics)
Vaping illness: FDA warns against tetrahydrocannabinol (THC)-containing liquids for e-cigarettes
Liver damage with newer combination drugs against hepatitis C
Life-threatening lung disease with CDK4/6 inhibitors

e a-t ON THE INTERNET
Andexanet alfa (ONDEXXYA) – antidote for rivaroxaban and apixaban (long version)
© 2024 arznei-telegramm